A team of researchers led by Shelly L. Gray at the University of Washington School of Pharmacy in Seattle analyzed data from over 161,000 middle-aged women and found that the patients who took PPIs were more likely to have osteoporosis or a history of fractures as well as other conditions.
The PPI side effects were not found to be related to hip fracture risk, though the researchers did find that the use of PPI and two other drugs increased the risk of clinical spine fracture by 47 percent, the relative risk of forearm or risk fracture by 26 percent and the relative risk of total fractures by 25 percent.
Read the full LawyersandSettlements.com report on fracture risk with PPI.
Read other coverage on hip replacement surgery:
– California’s Sutter Medical Center First in Nation to Use Next-Generation ROBODOC System for Joint Replacement
– Dr. Mark McFarland: The Future of Total Joint Replacement as an Outpatient Procedure
– Study: SSI More Likely for Total Knee or Hip Replacement Patients Receiving General Anesthesia
